Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2009
  • Online publication date: December 2009

Chapter 1 - Respiratory syncytial virus bronchiolitis

References

1. LeaderS, KohlhaseK. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002; 21: 629–32.
2. ShayDK, HolmanRC, NewmanRD, LiuLL, StoutJW, AndersonLJBronchiolitis-associated hospitalizations among US children, 1980–1996. J Am Med Assoc 1999; 282: 1440–6.
3. ShayDK, HolmanRC, Roosevelt, GE, ClarkeMJ, AndersonLJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis 2001.; 183(1): 16–22.
4. LangleyJM, LeBlancJC, SmithB, WangEEIncreasing incidence of hospitalization for bronchiolitis among Canadian children, 1980–2000. J Infect Dis 2003; 188: 1764–7.
5. LangleyJM, WangEE, LawBJet al. Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. J Pediatr 1997; 131: 113–17.
6. Piippo-SavolainenE, RemesS, KannistoS, KorhonenK, KorppiM. Asthma and lung function 20 years after wheezing in infancy: results from a prospective follow-up study. Arch Pediatr Adolesc Med 2004; 158: 1070–6.
7. HallCBRespiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917–28.
8. SchwarzeJ, O’DonnellDR, RohwedderA, OpenshawPJ. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004; 169: 801–5.
9. HallCB, DouglasRGJ, SchnabelKC, GeimanJM. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981; 33: 779–83.
10. HallCB, DouglasRG, Jr, GeimanJM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980; 141: 98–102.
11. O’DonnellDR, McGarveyMJ, TullyJM, Balfour-LynnIM, OpenshawPJ. Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. J Pediatr 1998; 133: 272–4.
12. KneyberMC, BrandenburgAH, de GrootRet al. Risk factors for respiratory syncytial virus associated apnoea. Eur J Pediatr 1998; 157: 331–5.
13. ChinJ, MagoffinRL, ShearerLA, SchiebleJH, LennetteEH. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 1969; 89: 449–63.
14. FulginitiVA, EllerJJ, SieberOF, JoynerJW, MinamitaniM, MeiklejohnG. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol 1969; 89: 435–48.
15. KapikianAZ, MitchellRH, ChanockRM, ShvedoffRA, StewartCE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969; 89: 405–21.
16. KimHW, CancholaJG, BrandtCDet al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969; 89: 422–34.
17. GrahamBS, BuntonLA, WrightPF, KarzonDTRole of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88: 1026–33.
18. OpenshawPJ. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin Immunopathol 1995; 17: 187–201.
19. HussellT, PennycookA, OpenshawPJInhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 2001; 31: 2566–73.
20. OpenshawPJ, CulleyFJ, OlszewskaW. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 2001; 20 Suppl 1: S27–31.
21. BarrJ, ChambersP, PringleCR, EastonAJ. Sequence of the major nucleocapsid protein gene of pneumonia virus of mice: sequence comparisons suggest structural homology between nucleocapsid proteins of pneumoviruses, paramyxoviruses, rhabdoviruses and filoviruses. J Gen Virol 1991; 72: 677–85.
22. GozalD, ColinAA, JaffeM, HochbergZ. Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis. Pediatr Res 1990; 27: 204–9.
23. HannaS, TibbySM, DurwardA, MurdochIA. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr 2003; 92: 430–4.
24. PoddarU, SinghiS, GanguliNK, SialyR. Water electrolyte homeostasis in acute bronchiolitis. Indian Pediatr 1995; 32: 59–65.
25. O’MalleyBW. Mechanisms of action of steroid hormones. N Engl J Med 1971; 284: 370–7.
26. FauciAS. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol 1976; 24: 54–62.
27. TaskerRC, RoeMF, BloxhamDM, WhiteDK, Ross-RussellRI, O’DonnellDR. The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy. Intens Care Med 2004; 30: 2257–62.
28. DanusO. [Bronchiolitis. Analysis of 30 cases treated with Meticorten]. Pediatria.(Santiago.) 1965; 8: 113–20.
29. WeinbergerM. Corticosteroids for first-time young wheezers: current status of the controversy. J Pediatr 2003; 143: 700–2.
30. CsonkaP, KailaM, LaippalaP, Iso-MustajarviM, VesikariT, AshornP.Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr 2003; 143: 725–30.
31. PatelH, PlattR, LozanoJM, WangEE. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2004; CD004878.
32. LeVineAM, GwozdzJ, StarkJ, BrunoM, WhitsettJ, KorfhagenT. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999; 103: 1015–21.
33. DargavillePA, SouthM, McDougallPN. Surfactant abnormalities in infants with severe viral bronchiolitis. Arch Dis Child 1996; 75: 133–6.
34. LofgrenJ, RametM, RenkoM, MarttilaR, HallmanM. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002; 185: 283–9.
35. O’DonnellDR, MilliganL, StarkJMInduction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 1999; 257: 198–207.
36. TibbySM, HatherillM, WrightSM, WilsonP, PostleAD, MurdochIA. Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2000; 162: 1251–6.
37. SchindlerMDo bronchodilators have an effect on bronchiolitis?Crit Care 2002; 6: 111–12.
38. KellnerJD, OhlssonA, GadomskiAM, WangEE. Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis. Arch Pediatr Adolesc Med 1996; 150: 1166–72.
39. KellnerJD, OhlssonA, GadomskiAM, WangEE. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2000; CD001266.
40. HartlingL, WiebeN, RussellK, PatelH, KlassenTP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004; CD003123.
41. CollinsPL, McIntoshK, ChannockRM.Respiratory syncytial virus. In: FieldsBN, KnipeDM, HowleyRMet al., eds. Fields Virology. Philadelphia, Lippincott-Raven, 1996; 1313–51.
42. KrilovLR, MandelFS, BaroneSR, FaginJC.Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. Pediatr Infect Dis J 1997; 16: 273–6.
43. LongCE, VoterKZ, BarkerWH, HallCB. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Pediatr Infect Dis J 1997; 16: 1023–8.
44. RodriguezWJ, ArrobioJ, FinkR, KimHW, MilburnC. Prospective follow-up and pulmonary functions from a placebo-controlled randomized trial of ribavirin therapy in respiratory syncytial virus bronchiolitis. Ribavirin Study Group. Arch Pediatr Adolesc Med 1999; 153: 469–74.
45. BuckJJ, DebenhamP, TaskerRC.Prophylaxis for respiratory syncytial virus infection: missing the target. Arch Dis Child 2001; 84(4): 375.
46. GhoshS, ChamplinRE, EnglundJ. et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transpl 2000; 25(7): 751–5.
47. SokolJ, JacobsSE, BohnD. Inhaled nitric oxide for acute hypoxemic respiratory failure in children and adults. Cochrane Database Syst Rev 2000; CD002787.
48. KneyberMC, Oud-AlblasHB, van VlietM, UiterwaalCS, KimpenJL, van VughtAJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intens Care Med 2005; 31: 680–5.
49. PurcellKFergieJ. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002; 156: 322–4.
50. DuttweilerL, NadalD, FreyB. Pulmonary and systemic bacterial co-infections in severe RSV bronchiolitis. Arch Dis Child 2004; 89: 1155–7.
51. FlamantC, HallalelF, NolentP, ChevalierJY, RenolleauS. Severe respiratory syncytial virus bronchiolitis in children: from short mechanical ventilation to extracorporeal membrane oxygenation. Eur J Pediatr 2005; 164: 93–8.
52. CrowcroftNS, BooyR, HarrisonTet al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88: 802–6.
53. KorppiM, LeinonenM, KoskelaM, MakelaPH, LaunialaK. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J 1989; 8: 687–92.
54. KonigB, KonigW, ArnoldR, WerchauH, IhorstG, ForsterJ. Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 2004; 42: 4632–5.
55. WangEE, LawBJ, BoucherFDet al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996; 129: 390–5.